Trial Profile
ED50 of Dexmedetomidine for Reduction of Emergence Agitation Incidence Undergoing Tonsillectomy or Adenoidectomy in Desflurane Anesthesia Following Sevoflurane Induction in Children.
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 08 Mar 2017
Price :
$35
*
At a glance
- Drugs Dexmedetomidine (Primary)
- Indications Agitation
- Focus Therapeutic Use
- 09 May 2012 Planned number of patients changed from 25 to 30 as reported by Korean Clinical Trials Register.
- 09 May 2012 New source identified and integrated (Clinical Research Information Service (CriS) - Republic of Korea; KCT0000126).
- 20 Jun 2011 New trial record